- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01457313
Pain Compared Between the First and the Second Surgery in Staged BTKA
Comparison of Postoperative Pain in the First and Second Knee in Staged Bilateral Total Knee Arthroplasty: Clinical Evidence That Central Sensitization Increases Systemic Pain Sensitivity
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Gyeonggi-Do
-
Seongnam, Gyeonggi-Do, Korea, Republic of, 463-787
- Recruiting
- Seoul National University Bundang Hopital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients undergoing elective bilateral staged total knee arthroplasty at a 1-week interval under spinal anesthesia,
- age <=85
- American Society of Anesthesiologists physical status of I to II
Exclusion Criteria: any contraindication to spinal anesthesia or femoral nerve block such as coagulopathy; conversion to general anesthesia; preexisting pain syndrome; abnormal liver function or renal test results; severe heart, liver, or renal disease; history of stroke or neurologic deficits; psychiatric disorder; chronic opioid use; drug dependency; allergy to study medications; inflammatory joint disease; previous surgery on or trauma of the knee; difference in preoperative VAS score of ≥ 20 (at rest and at maximum knee flexion) between each side of the knee; body mass index of ≥ 40 kg/m2; and inability to comprehend the VAS or to use patient-controlled analgesia (PCA.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
BTKA
patients undergoing bilateral staged total knee arthroplasty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS
Time Frame: from the end of the TKA surgery until postoperative 48 hour
|
visual analogue scale
|
from the end of the TKA surgery until postoperative 48 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
analgesic consumption
Time Frame: from the end of the TKA surgery until postoperative 48 hour
|
patient controlled analgesia (fentanyl)
|
from the end of the TKA surgery until postoperative 48 hour
|
|
rescue analgesic
Time Frame: from the end of the TKA surgery until postoperative 48 hour
|
ketoprofen
|
from the end of the TKA surgery until postoperative 48 hour
|
|
antiemetics
Time Frame: from the end of the TKA surgery until postoperative 48 hour
|
antiemetics total amount
|
from the end of the TKA surgery until postoperative 48 hour
|
Collaborators and Investigators
Investigators
- Study Chair: Sanghwan Do, PhD, Seoul National University Bundang Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TKA bilat pain
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.